Valeritas (NSDQ:VLRX) said today that it inked an expanded deal with Med Trust, its distribution partner in Austria and Germany, to promote and sell the V-Go wearable insulin delivery device in the Czech Republic and Slovakia. According to the terms of the deal, Valeritas will be responsible for product development, regulatory approval, quality management and manufacturing the device while […]
Tandem prices $100m offering
Tandem Diabetes Care (NSDQ:TNDM) has priced an underwritten public offering of 3.5 million shares of common stock at $28.50 apiece. The San Diego, Calif.-based company expects to reel in roughly $100 million in gross proceeds from the offering. Tandem also gave underwriters a 30-day option to buy up to 526,315 additional shares of common stock. The […]
OncoSec inks research deal to analyze clinical trial participants
OncoSec Medical (NSDQ:ONCS) said today that it inked a research deal with Dr. Roger Lo and his research team at the University of California Los Angeles to study participants from the biotech company’s Pisces/Keynote-695 Phase IIb clinical trial. Dr. Lo and his team are slated to perform genetic, transcriptomic and methylomic analyses of patients from OncoSec’s […]
Tackling drug delivery challenges with TissueGen’s implantable fibers
TissueGen‘s chief scientist and co-founder, Kevin Nelson, told Drug Delivery Business News the story behind the company he founded in 2000 and its drug delivery technology, the Elute fiber. DDBN: How did TissueGen get its start? Nelson: In 1996, while faculty in biomedical engineering at The University of Texas at Arlington, I was working with […]
ivWatch wins medical device license in Canada
ivWatch said today that it landed a medical device license from Health Canada permitting the sale of its intravenous infiltration/extravasation monitoring device. The company’s FDA-approved sensor, which is roughly the size of a pencil eraser, uses light to measure the optical density of the tissue surrounding an IV insertion site, monitoring the flow of fluid […]
Particle Sciences receives patent for device to deliver medication to the tympanic membrane
[PRESS RELEASE] – The Lubrizol Corporation announces its LifeSciences and Particle Sciences businesses, have received a Notice of Allowance on a device for the delivery of medication to the ear-drum. According to Rob Lee, president, Particle Sciences, “This latest patent is a clear-cut demonstration of our staff going beyond formulation to help our clients deliver […]
Valeritas touts use of V-Go device compared to insulin injections
Valeritas (NSDQ:VLRX) touted data today from an analysis showing that insulin-dependent people with Type 2 diabetes benefited from using the company’s wearable V-Go insulin delivery device. The study featured people who previously treated their diabetes using multiple daily injections of insulin. After switching to the V-Go device under the care of advanced practitioners, participants were monitored […]
Dexcom beats the Street with Q2 results
Dexcom (NSDQ:DXCM) topped sales and earnings expectations on Wall Street today with its second-quarter financial results. The San Diego, Calif.-based company posted profits of $30.2 million, or 34¢ per share, on sales of $242.5 million for the three months ended June 30, representing a whopping 941% increase in profits and a 42% increase in sales compared […]
Nemaura touts data from home-use study of wearable glucose monitor
Nemaura Medical (NSDQ:NMRD) said today that it launched a study of its wearable glucose monitor in the hopes of winning regulatory approval in the U.S. The England-based company touted positive interim data from the study, focusing on the at-home use of the sugarBeat device. The company’s interim results included findings from 25 patients with either Type […]
Baxter wins CE Mark for Evo IQ infusion system
Baxter (NYSE:BAX) said today that its Evo IQ infusion system won CE Mark clearance and regulatory approval in Australia. The company plans to start the launch process for its infusion system in the U.K., Ireland, New Zealand and Australia in the third quarter of this year. Baxter’s Evo IQ infusion system includes an advanced drug library, […]
